Remote Patient Monitoring Market

Rising  Geriatric Population to Fuels Market Growth

According to the World Health Organization the worldwide population over 60 is expected to grow from 12% in 2015 to 22% in 2050, increasing the risk of developing chronic diseases and complications. An increase in chronic diseases such as osteoarthritis, chronic obstructive pulmonary disease, diabetes, depression, heart disease and dementia are prevalent in this population. Therefore, various solutions for remote monitoring patients to treat these diseases are being increasingly used, which drives the market CAGR.

Furthermore, there is a growing need for continuous monitoring of vital signs and effective treatment of disease. For instance, according to a study published in the American Medical Informatics Association (JAMIA) Journal, remote patient monitoring boosts patient engagement in managing chronic diseases.

Technological advances and the cost advantages of remote patient monitoring have driven the adoption of remote patient monitoring technology for many years. People tend to monitor their health daily with home monitors. Patients can easily assess temperature, respiratory rate, heart rate, blood pressure and more via wearable devices in point-of-care settings without disrupting their daily lives. Devices are getting cheaper and cheaper as adoption increases. Thus, driving the  Remote Patient Monitoring market revenue.

Integration of AI and machine learning algorithms into RPM systems has allowed for more advanced predictive analytics. These systems can analyze vast amounts of patient data to predict potential health issues before they become critical, enabling proactive care.

For instance, Philips and Biofourmis are leading in AI-driven platforms providing real-time insights and early warnings for conditions like heart failure and COPD.

The Global Remote Patient Monitoring Market Industry is poised for remarkable growth, with projections indicating a market value of 21.7 USD Billion in 2024 and an anticipated surge to 151.0 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate of 19.3 percent from 2025 to 2035, driven by various factors including technological advancements, increasing chronic disease prevalence, and a shift towards patient-centric care models. The market's expansion is indicative of the growing recognition of remote monitoring as a critical component of modern healthcare delivery.

Rapid advancements in technology, particularly in wearable devices and mobile health applications, are transforming the Global Remote Patient Monitoring Market Industry. Innovations such as real-time data analytics, artificial intelligence, and cloud computing enhance the efficiency and effectiveness of remote monitoring. For example, wearable devices now enable continuous health tracking, allowing healthcare providers to receive timely data. This technological evolution is expected to drive the market's growth, with a compound annual growth rate of 19.3 percent projected from 2025 to 2035, reflecting the increasing integration of technology in healthcare.

The rising incidence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions is a pivotal driver of the Global Remote Patient Monitoring Market Industry. As healthcare systems grapple with the burden of these conditions, remote monitoring solutions offer a viable approach to manage patient health proactively. For instance, the World Health Organization indicates that chronic diseases account for 71 percent of all deaths globally. This trend necessitates innovative healthcare solutions, leading to an anticipated market value of 21.7 USD Billion in 2024, with projections suggesting it could reach 151.0 USD Billion by 2035.

The ongoing shift towards patient-centric care models is reshaping the Global Remote Patient Monitoring Market Industry. Healthcare providers are increasingly focusing on personalized care, emphasizing the importance of patient engagement and empowerment. Remote monitoring facilitates this shift by enabling patients to take an active role in managing their health. For instance, patients can monitor their vital signs and share data with healthcare providers, fostering collaborative care. This trend aligns with the broader movement towards value-based care, which prioritizes patient outcomes. As a result, the market is poised for substantial growth, with projections indicating a market value of 151.0 USD Billion by 2035.

Regulatory support and favorable reimbursement policies are crucial drivers of the Global Remote Patient Monitoring Market Industry. Governments and health organizations are increasingly recognizing the value of remote monitoring in enhancing healthcare delivery. Initiatives aimed at integrating remote monitoring into standard care protocols are gaining traction, supported by reimbursement frameworks that incentivize its adoption. For example, various countries are expanding Medicare and Medicaid coverage for remote monitoring services, facilitating broader access for patients. This supportive regulatory environment is likely to accelerate market growth, contributing to the projected compound annual growth rate of 19.3 percent from 2025 to 2035.

The escalating demand for cost-effective healthcare solutions is significantly influencing the Global Remote Patient Monitoring Market Industry. As healthcare costs continue to rise, both patients and providers are seeking alternatives that reduce expenses while maintaining quality care. Remote monitoring can decrease hospital readmissions and emergency visits, ultimately leading to lower healthcare costs. This trend is particularly relevant in regions with limited healthcare resources, where remote monitoring can bridge gaps in care. The market's growth trajectory, with an expected value of 21.7 USD Billion in 2024, underscores the financial advantages of adopting remote patient monitoring.

By region, the study offers market insights into Asia-Pacific, Europe, North America,  and Rest of the World. The North America remote patient monitoring market accounted for USD 1.00 billion in 2022 and is projected to display a significant CAGR growth during the study period attributed to the greater adoption of monitoring devices by patients and hospital settings. Moreover, Increasing investment in the introduction of sophisticated devices for enhanced quality care of the patient pool is accountable for the region dominant market share in 2022. 

North American market players constantly focus on product development and partnership strategies to expand their business offerings in North America. Further, the United States market of remote patient monitoring held the largest market share, and the Canada market of remote patient monitoring was the fastest-growing market in the North American region.

Further, the key countries studied in the market report are The U.S, Canada, UK, Italy, Spain, Germany, France, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3  REMOTE PATIENT MONITORING MARKET SHARE BY REGION 2022 (%)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe's remote patient monitoring market accounts for the second-largest market share due to the rapid adoption of the devices, favorable regulatory scenario, and availability of adequate healthcare infrastructure. In addition, strategic partnerships among the companies to offer whole remote patient monitoring to patients are contributing to the introduction of these monitoring devices in the region leading to higher adoption. 

Moreover, the UK market of remote patient monitoring held the largest market sharenwhereas Germany market of remote patient monitoring is the fast growing in the region.

The Asia-Pacific Remote Patient Monitoring Market is anticipated to grow at the fastest CAGR from 2024-2032. Rising patient responsiveness regarding blood glucose monitoring devices coupled with cardiac monitors leads to higher adoption of these devices in the region. 

In addition, the penetration of companies in rural areas and improving healthcare systems in countries such as India, Australia, and Southeast Asia are expected to drive the market. 

Key players are devising market entry strategies to expand their business presence in the Asia Pacific. Moreover, the China market of remote patient monitoring held the largest market sharenwhereas India market of remote patient monitoring is the fast growing in the Asia-Pacific region.

Key market players are spending a huge amount of money on research & development to increase their product lines, which will aid the market growth of remote patient monitoring. Market players are also taking numerous strategies to grow their  footprint, with vital market developments such as increased investments, contractual agreements, mergers, new product launches, and acquisitions, and collaboration with other organizations. Competitors in the remote patient monitoring industry must expand their business footprint to stay alive in an progressively competitive and mounting market atmosphere.

One of the major business strategies industries adopt in the  remote patient monitoring manufacturing to help clients and increase the market sector by increasing investment in R&D to improve solutions and services. In recent years, the remote patient monitoring industry has provided reduced disruptions and transparency in the supply chain. 

The remote patient monitoring market key player such as Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), GE Healthcare (US), Cerner Corporation (US), Siemens Healthineers AG (Germany), OMRON Healthcare (Japan), Boston Scientific Corporation (US), Abbott Laboratories (US), Nihon Kohden Corporation (Japan), OSI Systems, Inc. (US), Philips (US) and others are working on increasing the market demand by investing in research and development activities.

Philips is an American-based company that helps people to prevent disease and live healthily. Giving clinicians tools need to make a precision diagnosis and bring personalized treatment. For instance, In November 2019, Philips announced the launch of EarlyVue VS30, vital signs monitor in the U.S. The monitor aims to collect critical vital signs data and allow clinicians to appropriately identify the patient's health.

Medtronic plc is an American medical device company. It primarily operates in the United States, operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. For instance, in July 2020, Medtronic announced the clearance of Linq II insertable cardiac monitor (ICM) by the European CE mark and U.S. food and drug administration. The monitor is equipped with remote programming that allows clinicians to monitor patients and change device settings without the physical need of patients in hospitals and clinics.